| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 414,109 | 357,555 | 345,770 | 388,037 | | Cost of Revenue | 213,684 | 210,327 | 199,833 | 281,100 | | | Gross Profit | 200,425 | 147,228 | 145,937 | 106,937 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 125,239 | 115,016 | 110,669 | 127,378 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 75,186 | 32,212 | 35,268 | (20,441) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 2,037 | | Earnings Before Interest And Taxes | 71,979 | 32,212 | 35,268 | (18,404) | | Interest Expense | (2,155) | 1,078 | 1,077 | 3,607 | | Income Before Tax | 74,134 | 31,134 | 34,191 | (22,011) | | Income Tax Expense | 30,265 | 12,524 | 13,746 | (8,463) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 43,869 | 18,610 | 20,445 | (13,548) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 43,869 | 18,610 | 20,445 | (13,548) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $43,869 | $18,610 | $20,445 | ($13,548) |
|
0.01% Nasdaq 0.00%
Income Statement
